NYSE:IH 延时15分钟

成交量

Yu Feng Chi: Yu Feng Chi is the founder of Beijing Jinhongen Co. Ltd., founded in 1996. Dr. Chi was the founder of Perfect World Co., Ltd., founded in 2004, and served as Chairman from 2006 to 2015. Dr. Chi is the founder of iHuman, Inc., founded in 2016, and serves as Chairman since 2016. Dr. Chi is also the founder of Beijing Golden Human Co. Ltd... Dr. Chi previously served as Chairman at Beijing Perfect World Network Technology Co., Ltd., Shanghai Perfect World Network Technology Co., Ltd., Perfect World (Beijing) Digital Technology Co., Ltd., Perfect World Co., Ltd. (since 2015), and Hongen Education & Technology Co. Ltd. Dr. Chi is Director at Ledao Qiansheng (Tianjin) Technology Co., Ltd. Former positions include Executive Director & Manager at Jilin City Construction Holdings Group Co., Ltd., Independent Non-Executive Director at East Buy Holding Ltd. from 2018 to 2020, and Chief Technology Officer & Vice President at Unisplendour Corp. Ltd. from 2003 to 2004. Education includes an undergraduate degree from Tsinghua University in 1994, an MBA from China Europe International Business School in 2004, and a doctorate from Singapore Management University in 2019.

Peng Dai: Peng Dai is Co-Chief Executive Officer at iHuman, Inc. since 2026. Formerly, Mr. Dai was Senior Director-Strategy & Investment at Perfect World Co., Ltd. from 2015 to 2016. Mr. Dai completed undergraduate studies at Tsinghua University in 2002, graduate studies at Tsinghua University in 2004, and a doctorate at Tsinghua University in 2008.

Han Feng Chi: Mr. Han Feng Chi is on the Board of Directors at iHuman, Inc. He received his undergraduate degree from Shenzhen University.

Wei Wei Wang: Wei Wei Wang is currently Chief Financial Officer & Director at iHuman, Inc., a position held since 2020. Former roles include Senior Associate at PricewaterhouseCoopers Zhong Tian LLP from 2000 to 2004, and Secretary & Senior Vice President at Perfect World Co., Ltd. from 2016 to 2020. Education includes an MBA from UCLA Anderson School of Management conferred in 2006 and an undergraduate degree from Guanghua School of Management conferred in 2000.

Wendy Hayes: Ms. Wendy Hayes is an Independent Director at Apollomics, Inc. (United States), an Independent Non-Executive Director at SciClone Pharmaceuticals (Holdings) Ltd., an Independent Director at iHuman, Inc., a Venture Partner at FoundersX LLC, an Independent Director at Burning Rock Biotech Ltd. and a Member at The American Institute of Certified Public Accountants. She is on the Board of Directors at Apollomics, Inc. (United States), SciClone Pharmaceuticals (Holdings) Ltd., iHuman, Inc. and Burning Rock Biotech Ltd. Ms. Hayes was previously employed as an Independent Director by Apollomics, Inc., an Independent Director by TuSimple Holdings, Inc., an Independent Director by Gracell Biotechnologies, Inc., an Independent Director by Xinyuan Real Estate Co. Ltd., an Independent Director by Mogu, Inc., an Independent Director by TuanChe Ltd., a Senior Manager & Audit Partner by Deloitte & Touche Tohmatsu CPA Ltd. /Beijing/, and a Reporting Manager-SEC & U.S. GAAP by The PMI Group, Inc. She also served on the board at SharkNinja, Inc. She received her undergraduate degree from the University of International Business & Economics and an MBA from Cheung Kong Graduate School of Business.

Xue Nan Li: Xue Nan Li is currently an Independent Director at Qinchuan Machine Tool & Tool Group Share Co., Ltd. since 2021, at iHuman, Inc. since 2020, and at Guangdong Bawei Biotechnology Corp. starting in 2025. Dr. Li is also an Associate Professor at Cheung Kong Graduate School of Business since 2016. Former positions include Independent Director at Beijing ABT Networks Co., Ltd. and Assistant Professor at Stephen M. Ross School of Business from 2007 to 2011. Education includes a doctorate from Rochester Christian University conferred in 2008, an undergraduate degree from Peking University conferred in 1998, and a doctorate from the University of Massachusetts conferred in 2002.

洪恩教育